跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Bizazoline - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Bizazoline
Approved
STANDARD
Bizazoline
LABORATORIO REIG JOFRE, S.A.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
9ab65e31afa4efbc
Company
LABORATORIO REIG JOFRE, S.A.
Type
Standard
Approval Details
Approval Id
9ab65e31afa4efbc
Drug Approval Philippines Name
Bizazoline
Product Name
Bizazoline
Registration Number
DRP-7427
Brand Name
Bizazoline
Generic Name
Ceftazidime
Dosage Form
Powder for Injection (IV)
Dosage Strength
1g
Manufacturer
LABORATORIO REIG JOFRE, S.A.
Importer
PENTA LABS AUSTRALIA (PHILIPPINES)
Distributor
PENTA LABS AUSTRALIA (PHILIPPINES)
Issuance Date
28 September 2022
Expiry Date
25 October 2027
Pharmacologic Category
ANTIBACTERIAL (THIRD-GENERATION CEPHALOSPORIN)
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
9ab65e31afa4efbc
Type
Standard
Back to Philippines FDA Approvals